Device Trial Radar · NCT06560177
Biolinq External Interferent Protocol
Last checked: Nov 20, 2026Latest source record: Feb 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
31
Actual
Start
Sep 10, 2024
Primary completion
Sep 27, 2024
Study completion Sep 27, 2024
Sponsor
- Lead sponsor
- Biolinq Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 19, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the interference effect of acetaminophen (APAP) on the Biolinq MicroArray Intradermal Continuous Glucose Biowearable System during a single in-clinic day on Day 3 of the sensor wear period. All participants will be asked to wear the Biolinq System and a commercial CGM comparator for three days while taking fingersticks on a commercial Self-Monitoring Blood Glucose Meter. All participants will come back to the clinic on the third day of sensor wear for an in-clinic day which will include blood draws and fingersticks to compare glucose measurements to a Lab Analyzer. At the end of the in clinic day the subjects will have the sensors removed and then exit the study.
Conditions
- Diabetes
- Diabetes Mellitus
Interventions
The Biolinq MicroArray Intradermal Continuous Glucose Biowearable SystemDevice
All participants will wear 1 Biolinq System on volar forearm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Samples Where YSI Values Matched the Biolinq Sensor's Color During the First Hour Post Acetaminophen (APAP) Intake.Time frame: First hour post Acetaminophen (APAP) intake
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rocky Mountain Clinical Research
Idaho Falls, Idaho
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.